Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
复制标题
通过 microRNA-200/ZEB1 轴控制肿瘤细胞 PD-L1 表达和瘤内免疫抑制来调节转移。
DOI:
10.1038/ncomms6241
复制
发表时间:
2014-10-28
影响因子:
16.6
通讯作者:
Qin, F. Xiao-Feng
中科院分区:
文献类型:
--
作者:
Chen, Limo;Gibbons, Don L.;Goswami, Sangeeta;Cortez, Maria Angelica;Ahn, Young-Ho;Byers, Lauren A.;Zhang, Xuejun;Yi, Xiaohui;Dwyer, David;Lin, Wei;Diao, Lixia;Wang, Jing;Roybal, Jonathon D.;Patel, Mayuri;Ungewiss, Christin;Peng, David;Antonia, Scott;Mediavilla-Varela, Melanie;Robertson, Gordon;Jones, Steve;Suraokar, Milind;Welsh, James W.;Erez, Baruch;Wistuba, Ignacio I.;Chen, Lieping;Peng, Di;Wang, Shanshan;Ullrich, Stephen E.;Heymach, John V.;Kurie, Jonathan M.;Qin, F. Xiao-Feng
Immunosuppression of tumor-infiltrating lymphocytes (TIL) is a common feature of advanced cancer, but its biological basis has remained obscure. We demonstrate here a molecular link between epithelial-to-mesenchymal transition (EMT) and CD8+ TIL immunosuppression, two key drivers of cancer progression. We show that microRNA-200 (miR-200), a cell-autonomous suppressor of EMT and metastasis, targets PD-L1. Moreover, ZEB1, an EMT activator and transcriptional repressor of miR-200, relieves miR-200 repression of PD-L1 on tumor cells, leading to CD8+ T cell immunosuppression and metastasis. These findings are supported by robust correlations between the EMT score, miR-200 levels and PD-L1 expression in multiple human lung cancer datasets. In addition to revealing a link between EMT and T cell dysfunction, these findings also show that ZEB1 promotes metastasis through a heretofore unappreciated cell non-autonomous mechanism, and suggest that subgroups of patients in whom malignant progression is driven by EMT activators may respond to treatment with PD-L1 antagonists.
登录
查看更多内容
影响因子:
3.7
作者:
Kong D;Banerjee S;Ahmad A;Li Y;Wang Z;Sethi S;Sarkar FH
通讯作者:
Sarkar FH
DOI:
10.1038/nri3405
发表时间:
2013-04
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
15.3
作者:
Freeman, Gordon J.;Wherry, E. John;Ahmed, Rafi;Sharpe, Arlene H.
通讯作者:
Sharpe, Arlene H.
影响因子:
50.3
作者:
Hanahan, Douglas;Coussens, Lisa M.
通讯作者:
Coussens, Lisa M.
影响因子:
32.4
作者:
DIGHE, AS;RICHARDS, E;SCHREIBER, RD
通讯作者:
SCHREIBER, RD